Jacques Le Pendu

Title: Innovations by Jacques Le Pendu in Norovirus Research

Introduction

Jacques Le Pendu is a notable inventor based in Nantes, France. He has made significant contributions to the field of virology, particularly in the study of noroviruses. With a total of two patents to his name, his work focuses on methods for detecting and inhibiting the binding of noroviruses to human blood antigens.

Latest Patents

Le Pendu's latest patents include a method, composition, and kit for antigenic binding of norwalk-like viruses. This method involves detecting a Norwalk-Like Virus (NLV) in a biological sample by obtaining the sample, contacting it with human histo-blood group antigens, and detecting the resulting antigen-NLV complex. Additionally, he has developed a method for identifying compounds that can inhibit the binding between NLV and histo-blood group antigens. This method assesses whether a test compound decreases the binding of a standard compound known to bind at a determinant site of the NLV. His second patent focuses on antigenic binding patterns of norovirus to human histo-blood group antigens, providing a kit for determining norovirus infection and predicting susceptibility based on blood type.

Career Highlights

Throughout his career, Jacques Le Pendu has worked with esteemed institutions such as Children's Hospital Medical Center and the Institut National de la Santé et de la Recherche Médicale. His research has significantly advanced the understanding of how noroviruses interact with human hosts.

Collaborations

Le Pendu has collaborated with notable colleagues, including Xi Jason Jiang and Didier Dubreuil. Their combined expertise has contributed to the advancements in norovirus research and detection methods.

Conclusion

Jacques Le Pendu's innovative work in the field of virology, particularly regarding noroviruses, has led to important advancements in detection and prevention methods. His contributions continue to impact public health and scientific research.